Background
Methods
Study participants
Cardiovascular disease (CVD) risk assessment
Echocardiography
Coronary angiography
Specimen collection and the laboratory investigations
DNA extraction and In vitro amplification
Reverse multiplex hybridization
Statistical analysis
Results
Baseline characteristics of the study population
Characteristics | Controls (n = 34) | Patients (n = 23) |
p value | OR (95% CI) |
---|---|---|---|---|
Age, mean (y) | 54.7 ± 10.1 | 54.0 ± 10.1 | 0.810 | |
Gender | ||||
Females | 16 (47.1) | 6 (26.1) | 0.166 |
Reference
|
Males | 18 (52.9) | 17 (73.9) | 2.51 (0.79–7.94) | |
BMI, kg/m2
| 27.7 ± 1.86 | 28.1 ± 2.07 | 0.435 | |
Obesity | 6 (17.6) | 5 (21.7) | 0.742 | 1.29 (0.34–4.88) |
Smoking | -- | 13 (56.5) | ||
FH CAD | 12 (35.3) | 6 (26.1) | 0.567 | 0.64 (0.20–2.07) |
Hypertension | -- | 10 (43.5) | ||
Diabetes | 12 (35.3) | 7 (30.4) | 0.780 | 0.82 (0.25–2.49) |
Dyslipidemia | -- | 19 (82.6) | ||
Biochemical data | ||||
FBS (mg/dl) | 99.4 ± 25.7 | 145.6 ± 62.2 |
<0.001
| |
TC (mg/dl) | 170 ± 18.4 | 207 ± 61.5 |
0.001
| |
TG (mg/dl) | 103 ± 33.1 | 155 ± 54.4 |
<0.001
| |
LDL-c (mg/dl) | 74.9 ± 12.6 | 147 ± 66.3 |
<0.001
| |
HDL-c (mg/dl) | 48.6 ± 8.3 | 37.8 ± 11.4 |
<0.001
| |
No of risk factors | ||||
≤ 3 | 32 (94.1) | 9 (39.1) |
<0.001
|
Reference
|
> 3 | 2 (5.9) | 14 (60.9) |
24.8 (4.75–130)
| |
Premature CAD | -- | 9 (39.1) | ||
Previous events | -- | 18 (78.3) | ||
Stroke | -- | 1 (4.3) | ||
Lesion type | ||||
100% Normal | -- | 5 (21.7) | ||
< 50% Occlusion | -- | 3 (13.0) | ||
50- 99% Occlusion | -- | 9 (39.2) | ||
100% Occlusion | -- | 6 (26.1) | ||
Lesion site | ||||
Single VD | -- | 8 (34.8) | ||
Two VD | -- | 4 (17.4) | ||
Three VD | -- | 6 (26.1) | ||
CAD severity | ||||
Gensini score | -- | 14 (1.5–62) | ||
Vessel score | -- | 1.0 (0.0–3.0) | ||
Echo findings | ||||
Ejection fraction | – | 57.4 ± 7.98 | ||
Mild DD | -- | 20 (87.0) | ||
SWMA | -- | 9 (39.1) |
Genotype analysis of thrombotic and atherosclerotic variants
SNP | Genotypes | Controls (n = 34) | Patients (n = 23) |
P values | Crude OR (95% CI) | Adjusted OR (95% CI) |
---|---|---|---|---|---|---|
FV: Leiden
| Normal | 32 (94.1) | 20 (87.0) | 0.384 | 1.0 | 1.0 |
1691G > A | Hetero | 2 (5.9) | 3 (13.0) | 2.4 (0.3–15.6) | 3.08 (0.3–26.3) | |
p HWE | 0.859 | 0.737 | ||||
MAF (A) | 0.03 | 0.07 | 0.359 | 0.4 (0.05–3.1) | ||
FV: R2
| Normal | 30 (8 8.2) | 14 (60.9) |
0.024
| 1.0 | 1.0 |
H1299R | Hetero | 4 (11.8) | 9 (39.1) |
4.8 (1.2–18.3)
|
7.1 (1.49–33.6)
| |
4070A > G |
p HWE | 0.715 | 0.243 | |||
MAF (G) | 0.06 | 0.20 |
0.024
|
3.8 (1.12–13.5)
| ||
FII: PTH
| Normal | 34 (100) | 23 (100) | NA | NA | |
20210G > A |
p HWE | NA | NA | |||
FXIII
| Normal | 30 (88.2) | 17 (73.9) | 0.287 | 1.0 | 1.0 |
V34L | Hetero | 4 (11.8) | 6 (26.1) | 2.6 (0.6–10.7) | 2.29 (0.48–1.5) | |
p HWE | 0.715 | 0.471 | ||||
MAF (T) | 0.06 | 0.13 | 0.185 | 0.4 (0.09–1.6) | ||
MTHFR
| Normal | 22 (64.7) | 12 (52.2) |
0.017
| 1.0 | 1.0 |
677C > T | Hetero | 12 (35.3) | 6 (26.1) | 0.9 (0.2–3.1) | 0.82 (0.21–3.3) | |
Homo | 0 (0.0) | 5 (21.7) |
19 (1.0–388)
| |||
Dominant model | 12 (35.3) | 11 (47.8) | 1.6 (0.5–4.9) | |||
p HWE | 0.211 |
0.041
| ||||
MAF (T) | 0.18 | 0.35 |
0.037
|
2.4 (1.04–5.9)
| ||
MTHFR
| Normal | 10 (29.4) | 8 (34.8) | 0.648 | 1.0 | 1.0 |
1298A > C | Hetero | 16 (47.1) | 8 (34.8) | 0.6 (0.1–2.2) | 0.87 (0.21–3.6) | |
Homo | 8 (23.5) | 7 (30.4) | 1.1 (0.2–4.3) | 1.46 (0.33–6.4) | ||
Dominant model | 24 (70.6) | 15 (65.2) | 0.7 (0.2–2.4) | |||
p HWE | 0.745 | 0.146 | ||||
MAF (C) | 0.47 | 0.48 | 0.935 | 0.9 (0.4–2.1) | ||
PAI-1
| 4G/4G | 10 (29.4) | 7 (30.4) | 0.698 | 1.0 | 1.0 |
4G/5G | 4G/5G | 18 (52.9) | 10 (43.5) | 0.7 (0.2–2.7) | 1.15 (0.24–5.3) | |
5G/5G | 6 (17.6) | 6 (26.1) | 1.4 (0.3–6.3) | 1.36 (0.27–6.8) | ||
Dominant model | 24 (70.5) | 16 (69.6) | 0.9 (0.3–3.0) | |||
p HWE | 0.667 | 0.536 | ||||
MAF (5G) | 0.44 | 0.48 | 0.696 | 0.8 (0.4–1.8) |
SNP | Genotypes | Controls (n = 34) | Patients (n = 23) |
P values | Crude OR (95% CI) | Adjusted OR (95% CI) |
---|---|---|---|---|---|---|
FGB
| Normal | 22 (64.7) | 12 (52.2) | 0.636 | 1.0 | 1.0 |
-455G > A | Hetero | 10 (29.4) | 9 (39.1) | 1.6 (0.5–5.2) | 0.28 (0.02–3.1) | |
Homo | 2 (5.9) | 2 (8.7) | 1.8 (0.2–14.7) | 1.65 (0.1–20.2) | ||
Dominant model | 12 (35.3) | 11 (47.8) | 1.6 (0.5–4.9) | |||
p HWE | 0.557 | 0.866 | ||||
MAF (A) | 0.21 | 0.28 | 0.344 | 1.5 (0.6–3.6) | ||
HPA-1
| a/a | 26 (76.5) | 13 (56.5) | 0.112 | 1.0 | 1.0 |
a/b | a/b | 8 (23.5) | 8 (34.8) | 2.0 (0.6–6.5) | ||
b/b | 0 (0.0) | 2 (8.7) | 9.8 (0.4–21.9) |
4.0 (1.4–6.4)
| ||
Dominant model | 8 (23.5) | 10 (43.5) | 2.5 (0.7–7.8) | |||
p HWE | 0.436 | 0.638 | ||||
MAF (b) | 0.12 | 0.26 |
0.048
| 2.6 (0.9–7.1) | ||
ACE
| I/I | 6 (17.6) | 2 (8.7) |
<0.001
| 1.0 | 1.0 |
I/D | I/D | 26 (76.5) | 9 (39.1) | 1.0 (0.1–6.1) | 2.79 (0.3–29.7) | |
D/D | 2 (5.9) | 12 (52.2) |
18 (2.0–161)
|
88.3 (4.3–179)
| ||
Dominant model | 28 (82.4) | 21 (91.3) | 2.3 (0.4–12.2) | |||
p HWE | 0.001 | 0.866 | ||||
MAF (D) | 0.44 | 0.72 |
0.003
|
3.2 (1.4–7.1)
| ||
ApoB
| Normal | 34 (100) | 23 (100) | NA | NA | |
R3500Q |
p HWE | NA | NA | |||
ApoE
| E2/E2 | 0 (0.0) | 1 (4.3) |
0.009
| 1.0 | |
E2/E3/E4 | E2/E4 | 2 (5.9) | 1 (4.3) | 0.2 (0.0–8.8) | ||
E2/E3 | 20 (58.8) | 3 (13.0) | 0.05 (0.0–1.6) | |||
E3/E3 | 10 (29.4) | 15 (65.2) | 0.4 (0.01–13.2) | |||
E3/E4 | 2 (5.9) | 3 (13.0) | 0.4 (0.01–16.8) | |||
p HWEa
| 0.060 | 0.550 | ||||
E3 | 0.61 | 0.78 |
0.004
| 1.0 | ||
E2 | 0.32 | 0.13 |
0.08 (0.04–0.18)
| |||
E4 (MAF) | 0.06 | 0.09 | 0.61 (0.2–1.87) |
Haplotypesa
| Overall frequency | Controls (n = 34) | Patients (n = 23) |
P values | OR (95% CI) |
---|---|---|---|---|---|
Genotype combination: MTHFR 667C > T/1298A > C | |||||
CC-AA | 11 (19.3) | 8 (23.5) | 3 (13.0) | 0.150 |
Reference
|
CT-AA | 3 (5.3) | 2 (5.9) | 1 (4.3) | 1.3 (0.08–20.7) | |
TT-AA | 4 (7.0) | 0 (0.0) | 4 (17.4) | 21.8 (0.9–523) | |
CC-AC | 9 (15.8) | 6 (17.6) | 3 (13) | 1.3 (0.19–9.08) | |
CT-AC | 14 (24.6) | 10 (29.4) | 4 (17.4) | 1.06 (0.18–6.2) | |
TT–AC | 1 (1.8) | 0 (0.0) | 1 (4.3) | 7.2 (0.23–225) | |
CC-CC | 14 (24.6) | 8 (23.5) | 6 (26.1) | 2.0 (0.3–10.9) | |
CT-CC | 1 (1.8) | 0 (0.0) | 1 (4.3) | 7.2 (0.23–225) | |
Genotype combination: FVL 1691G > A/FVR 4070A > G | |||||
GG-AA | 41 (71.9) | 28 (82.4) | 13 (56.5) | 0.080 |
Reference
|
GG-AG | 11 (19.3) | 4 (11.8) | 7 (30.4) | 3.7 (0.9–15.18) | |
GA–AA | 3 (5.3) | 2 (5.9) | 1 (4.3) | 1.07 (0.08–12.9) | |
GA-AG | 2 (3.5) | 0 (0.0) | 2 (8.7) | 10.5 (0.47–235) | |
Block 1: MTHFR 667C > T/1298A > C | |||||
CC | 0.446 | 45.9 | 42.8 | 0.7437 | |
CA | 0.308 | 36.5 | 22.4 | 0.1114 | |
TA | 0.218 | 16.5 | 29.8 | 0.0926 | |
TC | 0.027 | 1.1 | 5 | 0.2134 | |
Block 2: FVL 1691G > A/FVR 4070A > G | |||||
GA | 0.856 | 91.2 | 77.4 |
0.0397
| |
GG | 0.1 | 5.9 | 16.1 | 0.075 | |
AA | 0.03 | 2.9 | 3 | 0.9767 | |
AG | 0.014 | 0 | 3.5 | 0.121 |
Interaction of both gene variants and traditional risk factors with disease risk
Association of traditional risk factors with disease phenotype
Risk factor | Gensini score |
P value | Occlusion |
P value | No of BVs |
P value | |||
---|---|---|---|---|---|---|---|---|---|
Low | High | <50% | ≥50% | SVD | MVD | ||||
Number | 14 | 9 | 8 | 15 | 8 | 10 | |||
Gender | |||||||||
Females | 6 (42.9) | 0 (0.0) |
0.048
| 2 (25.0) | 4 (26.7) | 1.00 | 5 (62.5) | 1 (10) |
0.043
|
Males | 8 (57.1) | 9 (100) | 6 (75.0) | 11 (73.3) | 3 (37.5) | 9 (90) | |||
Obesity | 2 (14.3) | 3 (33.3) | 0.343 | 0 (0.0) | 5 (33.3) | 0.122 | 2 (25) | 3 (30) | 1.00 |
Smoking | 6 (42.9) | 7 (77.8) | 0.197 | 4 (509 | 9 (60.0) | 0.685 | 2 (25) | 8 (80) |
0.020
|
FH CAD | 2 (14.3) | 4 (44.4) | 0.162 | 2 (25.0) | 4 (26.7) | 1.00 | 1 (12.5) | 4 (40) | 0.314 |
Hypertension | 7 (50.0) | 3 (33.3) | 0.669 | 3 (37.5) | 7 (46.7) | 1.00 | 5 (62.5) | 4 (40) | 0.637 |
Diabetes | 4 (28.6) | 3 (33.3) | 1.00 | 2 (25.0) | 5 (33.3) | 1.00 | 3 (37.5) | 3 (30) | 1.00 |
Dyslipidemia | 11 (79) | 8 (88.9) | 1.00 | 6 (75.0) | 13 (86.7) | 0.589 | 5 (62.5) | 9 (90) | 0.275 |
Premature CAD | 5 (35.7) | 4 (44.4) | 1.00 | 3 (37.5) | 6 (40) | 1.00 | 3 (37.5) | 4 (40) | 1.00 |
Previous events | 9 (64.3) | 9 (100) | 0.116 | 4 (50.0) | 14 (93.3) |
0.033
| 7 (87.5) | 9 (90) | 1.00 |
Association of gene variants with disease phenotype
Gene SNP | G | Gensini score |
P value | Occlusion |
P value | No of BVs |
P value | |||
---|---|---|---|---|---|---|---|---|---|---|
Low | High | <50% | ≥50% | SVD | MVD | |||||
Number | 14 | 9 | 8 | 15 | 8 | 10 | ||||
FVL
| N | 11 (78.6) | 9 (100) | 0.253 | 7 (87.5) | 13 (86.7) | 1.00 | 7 (87.5) | 9 (90) | 1.00 |
H | 3 (21.4) | 0 (0.0) | 1 (12.5) | 2 (13.3) | 1 (12.5) | 1 (10) | ||||
FVR
| N | 6 (42.9) | 8 (88.9) |
0.040
| 2 (25) | 12 (80) |
0.023
| 4 (50) | 9 (90) | 0.118 |
H | 8 (57.1) | 1 (11.1) | 6 (75) | 3 (20) | 4 (50) | 1 (10) | ||||
F13A1
| N | 12 (85.7) | 5 (55.6) | 0.162 | 6 (75) | 11 (73.3) | 1.00 | 7 (87.5) | 6 (60) | 0.314 |
H | 2 (14.3) | 4 (44.4) | 2 (25) | 4 (26.7) | 1 (12.5) | 4 (40) | ||||
MTHFR 1
| N | 8 (57.1) | 4 (44.4) | 0.558 | 4 (50) | 8 (53.3) | 0.962 | 6 (75) | 5 (50) | 0.234 |
H | 4 (28.6) | 2 (22.2) | 2 (25) | 4 (26.7) | 2 (25) | 2 (20) | ||||
M | 2 (14.3) | 3 (33.3) | 2 (25) | 3 (20) | 0 (0.0) | 3 (30) | ||||
MTHFR 2
| N | 4 (28.6) | 4 (44.4) |
0.035
| 4 (50) | 4 (26.7) | 0.250 | 2 (25) | 4 (40) | 0.167 |
H | 3 (21.5) | 5 (55.6) | 1 (12.5) | 7 (46.7) | 2 (25) | 5 (50) | ||||
M | 7 (50) | 0 (0.0) | 3 (37.5) | 4 (26.7) | 4 (50) | 1 (10) | ||||
PAI-1
| N | 5 (35.7) | 2 (22.2) | 0.730 | 2 (25) | 5 (33.3) | 0.660 | 3 (37.5) | 3 (30) | 0.869 |
H | 6 (42.9) | 4 (44.4) | 3 (37.5) | 7 (46.7) | 3 (37.5) | 5 (50) | ||||
M | 3 (21.4) | 3 (33.3) | 3 (37.5) | 3 (20) | 2 (25) | 2 (20) | ||||
FGB
| N | 7 (50) | 5 (55.6) | 0.490 | 3 (37.5) | 9 (60) | 0.583 | 5 (62.5) | 5 (50) | 0.799 |
H | 5 (35.7) | 4 (44.4) | 4 (50) | 5 (33.3) | 2 (25) | 4 (40) | ||||
M | 2 (14.3) | 0 (0.0) | 1 (12.5) | 1 (6.7) | 1 (12.5) | 1 (10) | ||||
HPA-1
| N | 7 (50) | 6 (66.7) | 0.595 | 4 (50) | 9 (60) | 0.851 | 6 (75) | 6 (60) | 0.610 |
H | 6 (42.9) | 2 (66.7) | 3 (37.5) | 5 (33.3) | 2 (25) | 3 (30) | ||||
M | 1 (7.1) | 1 (22.2) | 1 (12.5) | 1 (6.7) | 0 (0.0) | 1 (10) | ||||
ACE
| N | 1 (7.1) | 1 (11.1) | 0.829 | 1 (12.5) | 1 (6.7) | 0.894 | 0 (0.0) | 1 (10) | 0.287 |
H | 5 (35.7) | 4 (44.4) | 3 (37.5) | 6 (40) | 2 (25) | 5 (50) | ||||
N | 8 | 4 (44.4) | 4 (50) | 8 (53.3) | 6 (75) | 4 (40) | ||||
ApoE
| 2/2 | 0 (0.0) | 1 (11.1) | 0.492 | 0 (0.0) | 1 (6.7) | 0.658 | 0 (0.0) | 1 (10) | 0.834 |
2/3 | 2 (14.3) | 1 (11.1) | 1 (12.5) | 2 (13.3) | 1 (12.5) | 1 (10) | ||||
2/4 | 1 | 0 (0.0) | 1 (12.5) | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||||
3/3 | 10 | 5 (55.6) | 5 (62.5) | 10 (66.6) | 6 (75) | 7 (70) | ||||
3/4 | 1 | 2 (66.7) | 1 (12.5) | 2 (13.3) | 1 (12.5) | 1 (10) |